| 1 |
33753246 | Celastrol in metabolic diseases: Progress and application prospects. | 2021 May |
1 |
| 2 |
30287053 | Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway. | 2019 Apr |
2 |
| 3 |
29667734 | Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA. | 2018 Oct |
5 |
| 4 |
30439604 | Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway. | 2018 Dec |
4 |
| 5 |
28161417 | Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes. | 2017 Mar 15 |
6 |
| 6 |
27110686 | Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice. | 2016 Apr 25 |
2 |
| 7 |
25961164 | Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells. | 2015 May 7 |
6 |
| 8 |
25474091 | Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways. | 2014 Dec 2 |
1 |